Brief: Macrogen to sell its entire stake in MG MED for 22.61 bln won
Oct 30 (Reuters) - Macrogen Inc 038290.KQ :
* Says it plans to sell its entire 1.6 million shares of MG
MED,
Inc., a molecular diagnosis company, for 22.61 billion won
Source text in Korean: https://goo.gl/DbgBiP
Further company coverage: 038290.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Macrogen
See all newsBrief: Macrogen Wins 17.6 Billion Won Order
Brief: Macrogen Inc Chosen As Preferred Bidder For 17.6 Billion Won Deal
Brief: Macrogen To Invest 38 Billion Won In Buidling Genome Centre In Songdo, South Korea
Brief: Macrogen Approved For Export Of Its Covid-19 Test Kit
Brief: Macrogen Signs License And Supply Agreement With Thermo Fisher Scientific